SECISBP2L and myeloid sarcoma: One such subset, SLAN+ DC, represents a subfraction of CD14+/CD16+ monocytes with pronounced pro-inflammatory activities that has been shown to accumulate in highly inflammatory brain lesions in MS patients (53).